• WHO abandons plans for crucial second phase of COVID-origins investigat

    From alien@21:1/5 to All on Fri Feb 17 23:16:11 2023
    Interesting article from nature. In short, it is saying that the second phase is canceled.

    Summary:
    The World Health Organization (WHO) has halted its second phase of investigation into the origins of COVID-19, citing the ongoing challenges of conducting studies in China. A team of experts visited Wuhan in January 2021, and in March of that year, released a report outlining four possible
    scenarios. The most likely was that the virus spread from bats to people, possibly through an intermediate species. The team planned to follow up with a second phase of in-depth studies, but the WHO has abandoned the plans due to ongoing political tensions and issues with access to China. Some researchers are continuing to work on efforts to trace the origins of the virus.

    Original link
    <https://www.nature.com/articles/d41586-023-00283-y>
    doi: <https://doi.org/10.1038/d41586-023-00283-y>
    backup link from archive: <https://web.archive.org/web/20230214123831/https://www.nature.com/articles/d41586-023-00283-y>

    Article
    -----------
    The World Health Organization (WHO) has quietly shelved the second phase of
    its much-anticipated scientific investigation into the origins of the COVID-19 pandemic, citing ongoing challenges over attempts to conduct crucial studies
    in China, Nature has learned.

    Researchers say they are disappointed that the investigation isn’t going ahead, because understanding how the coronavirus SARS-CoV-2 first infected people is important for preventing future outbreaks. But without access to China, there is little that the WHO can do to advance the studies, says Angela Rasmussen, a virologist at the University of Saskatchewan in Saskatoon,
    Canada. “Their hands are really tied.”

    In January 2021, an international team of experts convened by the WHO
    travelled to Wuhan, China, where the virus that causes COVID-19 was first detected. Together with Chinese researchers, the team reviewed evidence on
    when and how the virus might have emerged, as part of phase one. The team released a report in March that year outlining four possible scenarios, the most likely being that SARS-CoV-2 spread from bats to people, possibly through an intermediate species. Phase one was designed to lay the groundwork for a second phase of in-depth studies to pin down exactly what happened in China
    and elsewhere.

    But two years since that high-profile trip, the WHO has abandoned its
    phase-two plans. “There is no phase two,” Maria Van Kerkhove, an epidemiologist at the WHO in Geneva, Switzerland, told Nature. The WHO planned for work to be done in phases, she said, but “that plan has changed”. “The
    politics across the world of this really hampered progress on understanding
    the origins,” she said.

    Researchers are undertaking some work to pin down a timeline of the virus’s initial spread. This includes efforts to trap bats in regions bordering China in search of viruses closely related to SARS-CoV-2; experimental studies to help narrow down which animals are susceptible to the virus and could be
    hosts; and testing of archived wastewater and blood samples collected around the world in late 2019 and early 2020. But researchers say that too much time has passed to gather some of the data needed to pinpoint where the virus originated.
    Tense times

    Many researchers aren’t surprised the WHO’s plans have been thwarted. In early
    2020, members of then US president Donald Trump’s administration made unsubstantiated claims that the virus had originated in a Chinese laboratory, and US intelligence officials later said they had begun investigations. The city of Wuhan is home to the Wuhan Institute of Virology, a high-security lab that works on coronaviruses. Chinese officials questioned whether the virus originated inside the country’s borders.

    Amid simmering hostility between the two superpowers, WHO member states requested in May 2020 that the agency put together a science-led effort to identify how the pandemic started. Although China agreed to the mission, tensions were high by the time the WHO group left for Wuhan, and engagement with China quickly unravelled after the group returned.

    In its March 2021 report, the team concluded that it was “extremely unlikely”
    that the virus had accidentally escaped from a laboratory. But the inclusion
    of the lab-incident scenario in the final report was a key point of contention for Chinese researchers and officials, says Dominic Dwyer, a virologist at New South Wales Health Pathology in Sydney, who was a member of the WHO team.

    That July, the WHO sent a circular to member states outlining how it planned
    to advance origins studies. Proposed steps included assessing wild-animal markets in and around Wuhan and the farms that supplied those markets, as well as audits of labs in the area where the first cases were identified.

    But Chinese officials rejected the WHO’s plans, taking particular issue with the proposal to investigate lab breaches. Zhao Lijian, the spokesperson for China’s foreign ministry, said the WHO proposal was not agreed by all member states, and that the second phase should not focus on pathways the mission report had already deemed extremely unlikely.

    In August 2021, members of the original mission team published a Comment piece in Nature urging quick action on the proposed studies to trace the virus’s origins. “We wrote that piece because we were worried phase two might not happen,” says Marion Koopmans, a virologist at Erasmus University Medical Center in Rotterdam, the Netherlands, and a member of the mission to Wuhan. “I’m sorry to say that that’s indeed what panned out.”
    Stalled work

    Gerald Keusch, associate director of the National Emerging Infectious Diseases Laboratory Institute at Boston University in Massachusetts, says the origins investigation was “poorly handled by the global community. It was poorly handled by China. It was poorly handled by the WHO.” The WHO should have been relentless in creating a positive working relationship with the Chinese authorities, says Keusch; if it was being stonewalled, it should have been honest about that.

    Van Kerkhove says that the WHO’s director-general, Tedros Adhanom Ghebreyesus,
    has continued to engage directly with Chinese government officials to
    encourage China to be more open and to share data. And WHO staff have reached out to the China Center for Disease Control and Prevention in Beijing to try
    to establish collaborations. “We really, really want to be able to work with our colleagues there,” says Van Kerkhove. “It’s really a deep frustration.”

    The Chinese ministry of foreign affairs did not respond to Nature’s e-mailed requests for comment on why the phase-two studies have stalled.

    In November 2021, the WHO formed the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) — a permanent team of experts who have since written
    a proposal for how to conduct origins studies for future outbreaks. SAGO has also evaluated evidence on the origins of SARS-CoV-2.
    Blood-donors study

    Outside the formal WHO-led process, some studies proposed for phase two have gone ahead. In May last year, researchers in Beijing and Wuhan published the results1 of an analysis of donor blood supplied to the Wuhan Blood Center before December 2019. The researchers were looking for SARS-CoV-2 antibodies that could signify some of the earliest infections in the pandemic. The team screened more than 88,000 plasma samples collected between 1 September and 31 December 2019, but did not find any SARS-CoV-2-blocking antibodies in the samples.

    Michael Worobey, an evolutionary virologist at the University of Arizona in Tucson, says the work is an important contribution from Chinese scientists, supporting earlier genomic analyses2 showing that the virus probably had not emerged as early as September and was not widespread in Wuhan in late 2019.

    Another study3 by researchers from China, which has not been peer reviewed, reported finding traces of SARS-CoV-2 in January and February 2020 at the Huanan seafood market in Wuhan, which was visited by many of the earliest
    known people with COVID-194. Samples were taken from sewage, drains, the surfaces of doors and market stalls, and the ground, among other places. The researchers concluded that the virus was probably shed by humans, but
    Rasmussen and others are keen to take a closer look at the raw data, which included swabs from a defeathering machine, to see whether they can identify animal species.

    “I still hope that progress will be made,” says Thea Fischer, a public-health
    virologist at the University of Copenhagen, who was a member of the mission to Wuhan and is part of SAGO.

    --
    -alien-
    ~ Work like you don't need the money. ~
    ~ Love like you've never been hurt. ~
    ~ Dance like nobody is looking. ~

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From Y A@21:1/5 to alien on Tue Feb 21 08:43:55 2023
    Hey. Are You tall ? What is Your height ? I am not very tall, 177 cm.



    On Saturday, February 18, 2023 at 1:16:13 AM UTC+2, alien wrote:
    Interesting article from nature. In short, it is saying that the second phase
    is canceled.

    Summary:
    The World Health Organization (WHO) has halted its second phase of investigation into the origins of COVID-19, citing the ongoing challenges of conducting studies in China. A team of experts visited Wuhan in January 2021,
    and in March of that year, released a report outlining four possible scenarios. The most likely was that the virus spread from bats to people, possibly through an intermediate species. The team planned to follow up with a
    second phase of in-depth studies, but the WHO has abandoned the plans due to ongoing political tensions and issues with access to China. Some researchers are continuing to work on efforts to trace the origins of the virus.

    Original link
    <https://www.nature.com/articles/d41586-023-00283-y>
    doi: <https://doi.org/10.1038/d41586-023-00283-y>
    backup link from archive: <https://web.archive.org/web/20230214123831/https://www.nature.com/articles/d41586-023-00283-y>

    Article
    -----------
    The World Health Organization (WHO) has quietly shelved the second phase of its much-anticipated scientific investigation into the origins of the COVID-19
    pandemic, citing ongoing challenges over attempts to conduct crucial studies in China, Nature has learned.

    Researchers say they are disappointed that the investigation isn’t going ahead, because understanding how the coronavirus SARS-CoV-2 first infected people is important for preventing future outbreaks. But without access to China, there is little that the WHO can do to advance the studies, says Angela
    Rasmussen, a virologist at the University of Saskatchewan in Saskatoon, Canada. “Their hands are really tied.”

    In January 2021, an international team of experts convened by the WHO travelled to Wuhan, China, where the virus that causes COVID-19 was first detected. Together with Chinese researchers, the team reviewed evidence on when and how the virus might have emerged, as part of phase one. The team released a report in March that year outlining four possible scenarios, the most likely being that SARS-CoV-2 spread from bats to people, possibly through
    an intermediate species. Phase one was designed to lay the groundwork for a second phase of in-depth studies to pin down exactly what happened in China and elsewhere.

    But two years since that high-profile trip, the WHO has abandoned its phase-two plans. “There is no phase two,” Maria Van Kerkhove, an epidemiologist at the WHO in Geneva, Switzerland, told Nature. The WHO planned
    for work to be done in phases, she said, but “that plan has changed”. “The
    politics across the world of this really hampered progress on understanding the origins,” she said.

    Researchers are undertaking some work to pin down a timeline of the virus’s
    initial spread. This includes efforts to trap bats in regions bordering China
    in search of viruses closely related to SARS-CoV-2; experimental studies to help narrow down which animals are susceptible to the virus and could be hosts; and testing of archived wastewater and blood samples collected around the world in late 2019 and early 2020. But researchers say that too much time
    has passed to gather some of the data needed to pinpoint where the virus originated.
    Tense times

    Many researchers aren’t surprised the WHO’s plans have been thwarted. In early
    2020, members of then US president Donald Trump’s administration made unsubstantiated claims that the virus had originated in a Chinese laboratory,
    and US intelligence officials later said they had begun investigations. The city of Wuhan is home to the Wuhan Institute of Virology, a high-security lab
    that works on coronaviruses. Chinese officials questioned whether the virus originated inside the country’s borders.

    Amid simmering hostility between the two superpowers, WHO member states requested in May 2020 that the agency put together a science-led effort to identify how the pandemic started. Although China agreed to the mission, tensions were high by the time the WHO group left for Wuhan, and engagement with China quickly unravelled after the group returned.

    In its March 2021 report, the team concluded that it was “extremely unlikely”
    that the virus had accidentally escaped from a laboratory. But the inclusion of the lab-incident scenario in the final report was a key point of contention
    for Chinese researchers and officials, says Dominic Dwyer, a virologist at New
    South Wales Health Pathology in Sydney, who was a member of the WHO team.

    That July, the WHO sent a circular to member states outlining how it planned to advance origins studies. Proposed steps included assessing wild-animal markets in and around Wuhan and the farms that supplied those markets, as well
    as audits of labs in the area where the first cases were identified.

    But Chinese officials rejected the WHO’s plans, taking particular issue with
    the proposal to investigate lab breaches. Zhao Lijian, the spokesperson for China’s foreign ministry, said the WHO proposal was not agreed by all member
    states, and that the second phase should not focus on pathways the mission report had already deemed extremely unlikely.

    In August 2021, members of the original mission team published a Comment piece
    in Nature urging quick action on the proposed studies to trace the virus’s origins. “We wrote that piece because we were worried phase two might not happen,” says Marion Koopmans, a virologist at Erasmus University Medical Center in Rotterdam, the Netherlands, and a member of the mission to Wuhan. “I’m sorry to say that that’s indeed what panned out.”
    Stalled work

    Gerald Keusch, associate director of the National Emerging Infectious Diseases
    Laboratory Institute at Boston University in Massachusetts, says the origins investigation was “poorly handled by the global community. It was poorly handled by China. It was poorly handled by the WHO.” The WHO should have been
    relentless in creating a positive working relationship with the Chinese authorities, says Keusch; if it was being stonewalled, it should have been honest about that.

    Van Kerkhove says that the WHO’s director-general, Tedros Adhanom Ghebreyesus,
    has continued to engage directly with Chinese government officials to encourage China to be more open and to share data. And WHO staff have reached
    out to the China Center for Disease Control and Prevention in Beijing to try to establish collaborations. “We really, really want to be able to work with
    our colleagues there,” says Van Kerkhove. “It’s really a deep frustration.”

    The Chinese ministry of foreign affairs did not respond to Nature’s e-mailed
    requests for comment on why the phase-two studies have stalled.

    In November 2021, the WHO formed the Scientific Advisory Group for the Origins
    of Novel Pathogens (SAGO) — a permanent team of experts who have since written
    a proposal for how to conduct origins studies for future outbreaks. SAGO has also evaluated evidence on the origins of SARS-CoV-2.
    Blood-donors study

    Outside the formal WHO-led process, some studies proposed for phase two have gone ahead. In May last year, researchers in Beijing and Wuhan published the results1 of an analysis of donor blood supplied to the Wuhan Blood Center before December 2019. The researchers were looking for SARS-CoV-2 antibodies that could signify some of the earliest infections in the pandemic. The team screened more than 88,000 plasma samples collected between 1 September and 31
    December 2019, but did not find any SARS-CoV-2-blocking antibodies in the samples.

    Michael Worobey, an evolutionary virologist at the University of Arizona in Tucson, says the work is an important contribution from Chinese scientists, supporting earlier genomic analyses2 showing that the virus probably had not emerged as early as September and was not widespread in Wuhan in late 2019.

    Another study3 by researchers from China, which has not been peer reviewed, reported finding traces of SARS-CoV-2 in January and February 2020 at the Huanan seafood market in Wuhan, which was visited by many of the earliest known people with COVID-194. Samples were taken from sewage, drains, the surfaces of doors and market stalls, and the ground, among other places. The researchers concluded that the virus was probably shed by humans, but Rasmussen and others are keen to take a closer look at the raw data, which included swabs from a defeathering machine, to see whether they can identify animal species.

    “I still hope that progress will be made,” says Thea Fischer, a public-health
    virologist at the University of Copenhagen, who was a member of the mission to
    Wuhan and is part of SAGO.

    --
    -alien-
    ~ Work like you don't need the money. ~
    ~ Love like you've never been hurt. ~
    ~ Dance like nobody is looking. ~

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)